Evidence-based clinical practice guidelines for IgA nephropathy 2014.
Fujita Health University School of Medicine, Toyoake, Japan. yukio-y@fujita-hu.ac.jp.
Yukio
Y
Yuzawa
Osaka University Graduate School of Medicine, Suita, Japan.
Ryohei
R
Yamamoto
Fujita Health University School of Medicine, Toyoake, Japan.
Kazuo
K
Takahashi
National Fukuoka-Higashi Medical Center, Koga, Japan.
Ritsuko
R
Katafuchi
Fujita Health University School of Medicine, Toyoake, Japan.
Makoto
M
Tomita
Teikyo University School of Medicine, Tokyo, Japan.
Yoshihide
Y
Fujigaki
Chiba East Hospital, Chiba, Japan.
Hiroshi
H
Kitamura
Kyoto Medical Center, Kyoto, Japan.
Masashi
M
Goto
Kichijoji Asahi Hospital, Tokyo, Japan.
Takashi
T
Yasuda
JCHO Sendai Hospital, Sendai, Japan.
Mitsuhiro
M
Sato
Tokushima University Graduate School, Tokushima, Japan.
Maki
M
Urushihara
Tokushima University Graduate School, Tokushima, Japan.
Shuji
S
Kondo
Tokushima University Graduate School, Tokushima, Japan.
Shoji
S
Kagami
Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yoshinari
Y
Yasuda
University of Miyazaki Hospital, Miyazaki, Japan.
Hiroyuki
H
Komatsu
Asahikawa Medical University, Asahikawa, Japan.
Miki
M
Takahara
Asahikawa Medical University, Asahikawa, Japan.
Yasuaki
Y
Harabuchi
St. Marianna University School of Medicine, Kawasaki, Japan.
Kenjiro
K
Kimura
Nagoya University Graduate School of Medicine, Nagoya, Japan.
Seiichi
S
Matsuo
D019317:Evidence-Based Medicine; D005922:Glomerulonephritis, IGA / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D006801:Humans